Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Hepatitis B surface antigen (HBsAg)-derived peptides presented on MHC molecules (HBsAg peptides-MHC)
- Target
- HBsAg peptides-MHC
- Molecular classification
- Peptide antigen, MHC complex, Viral protein fragment
01
Overview
The presentation of hepatitis B surface antigen (HBsAg)-derived peptides to T cells is a key process in HBV vaccination and immunotherapy. APCs process HBsAg into peptides, present them on MHC molecules, and activate CD4+ and CD8+ T cells, leading to viral clearance and immunological memory. The process depends on HLA allele type and T cell receptor specificity.
- Other names
- HBsAg epitopesHepatitis B surface antigen peptidesMHC-HBsAg complexes
02
Mechanism of action
Presentation of processed HBsAg-derived peptides via MHC molecules to T cells, leading to T cell activation, cytokine production, and cytotoxic activity.
03
Biological functions
T cell activationAntigen presentationAdaptive immunityViral clearanceImmunological memory
04
Disease associations
Hepatitis B virus infectionHepatocellular carcinoma
05
Safety considerations
HLA restriction affecting vaccine efficacyPotential for immune escape due to viral mutationsAutoimmune responsesOff-target effects of engineered T cells
06
Interacting drugs
Hepatitis B vaccines
2 more in the full profile.
07
Biomarkers
HLA allele typeT cell receptor specificity for HBsAg peptidesIFN-γ production by T cellsAnti-HBs antibody titers
Beyond the preview
Go deeper on Hepatitis B surface antigen (HBsAg)-derived peptides presented on MHC molecules (HBsAg peptides-MHC).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Hepatitis B surface antigen (HBsAg)-derived peptides presented on MHC molecules (HBsAg peptides-MHC).